Advanced search
Publication Cover
South African Family Practice Volume 52, 2010 - Issue 1
Journal homepage
196
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The value of pimecrolimus in improving quality of life of children with severe eczema—an open non-randomised study

O KitchinDepartment of Paediatrics and Child Health, Division of Paediatric Pulmonology, University of PretoriaCorrespondence[email protected]
, MBChB, FCPaed(SA), Dip Allerg(SA),
R MasekelaDepartment of Paediatrics and Child Health, Division of Paediatric Pulmonology, University of Pretoria
, MBBCh, MMed(Paed), Dip Allerg(SA), Cert Pulm(SA) Paed,
T MoodleyDepartment of Paediatrics and Child Health, Division of Paediatric Pulmonology, University of Pretoria
, MBChB, FCPaed, Dip Allerg(SA) &
R GreenDepartment of Paediatrics and Child Health, Division of Paediatric Pulmonology, University of Pretoria
, MB BCh, DCH, FCP(SA), DTM&H, MMed(Paed), FCCP, PhD, Dip Allerg(SA)
Pages 69-71 | Received 10 Apr 2009, Accepted 04 Jul 2009, Published online: 15 Aug 2014

References

  • Kemp AS, Varigos GA, Nolan TM, Su JC. Atopic eczema: Its impact on the family and financial costs. Arch Dis Child 1997;76;159–62.
  • Whalley D, Huels J, Mckeena SP, van Assche D. Benefit of pimecrolimus on parents quality of life in treatment of paediatric atopic eczema. Paediatrics 2002;110:1133–6.
  • Manjra AI, du Plessis P, Weiss R, et al. Childhood atopic eczema consensus document. Current Allergy Clinical Immunology 2005;18:121–6.
  • Zar HJ, Ehrlich RI, Workman L, Weinberg EG. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescence from 1995 to 2002. Pediatr Allergy Immunol. 2007;18:560–5.
  • Leung DYM, Sampson HA, Geha RS, Szefler SJ, editors. Paediatric Allergy principles and practice. St. Louis: Mosby;2003.
  • Pimecrolimus (Elidel) package insert, Novartis pharmaceuticals 2006.
  • Kapp A, Papp K, Bingham A, et al. Long term management of atopic dermatitis in infants with topical pimecrolimus an anti-inflammatory drug. J Allergy Clin Immunol 2002;2:277–84.
  • Siegfried E, Korman N, Molina C, Kianifard F, Abrams K. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroid for major flares in infants and children with atopic dermatitis. J Dermatolog Treat. 2006;17:143–50.
  • Whan U, Bos JD, Goodfield M, et al. Efficacy and safety of pimecrolimus cream in long term management of atopic dermatitis in children. Pediatrics 2002;110:e2 http://paediatrics.aapublications.org/cgi/content/abstract/110/1/e2 (Accessed 8 Jan 2008).
  • Spergel JM, Boguniewicz M, Paller AS, Hebert AA, Gallagher PR, McCormick C, et al. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. Br J Dermatol 2007;157:378–81.
  • Potter PC. Commentary on revised nomenclature for allergy released by EAACI Nomenclature Task Force. Current Allergy Clinical Immunology 2002;6:92–4.
  • Morris A. ABC of Allergology. Current Allergy Clinical Immunology 2005;18:140–2.
  • West DP. Topical calcineurin inhibitors in management of atopic dermatitis. http://www.medscape.com/viewprogram/5896 (Accessed 8 Jan 2008).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.